Cost-of-care discussions rarely documented for patients with advanced cancer

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

A large population-based pilot study led by researchers at the American Cancer Society and NCI shows cost discussions were infrequently documented in medical records of patients diagnosed with advanced non-small cell lung cancer and melanoma, which may hinder identifying patient financial needs and tracking outcomes of associated referrals. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

For decades, we have faced a central challenge in colorectal cancer screening. One in three eligible Americans—over 50 million people—remain unscreened despite established methods like colonoscopy or stool-based tests existing for decades. This gap persists even though early detection saves lives, and even as colorectal cancer is now the number one cancer killer for Americans under 50.
How’s this for a paradox: The better cancer centers become at keeping patients alive, the more expensive cancer care becomes. This brutal tradeoff hits harder in rural areas, where the cancer burden is higher and the investigator and clinical trial representation is lower.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login